Additionally, the pharmacology of the active parts was largely uncharacterized, and affirmation of SCB use was hindered by a lack of regarded biomarkers. These know-how gaps prompted scientists across multiple disciplines to speedily (one) keep track of, recognize and quantify with chromatography/mass spectrometry the ever-modifying contents of her